Gaush Meditech Ltd (FRA:F7Y)

Germany · Delayed Price · Currency is EUR

0.4280

-0.0180 (-4.04%)

Last updated: Oct 23, 2026, 8:03 AM CEST

Market Cap	62.72M -55.8%
Revenue (ttm)	170.40M -8.1%
Net Income	9.73M -25.9%
EPS	0.07 -24.2%
Shares Out	n/a
PE Ratio	6.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,900
Open	0.4280
Previous Close	0.4460
Day's Range	0.4280 - 0.4280
52-Week Range	0.4280 - 1.0300
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Gaush Meditech

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refrac... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Employees 890

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol F7Y

Financial Performance

In 2025, Gaush Meditech's revenue was 1.38 billion, a decrease of -3.36% compared to the previous year's 1.43 billion. Earnings were 96.19 million, an increase of 4.11%.

Financial numbers in CNY Financial Statements